FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid
BRUSSELS - The European Commission has paid 336 million euros to secure at least 300 million doses of the potential COVID-1 vaccine being developed by British drug maker AstraZeneca , a spokesman said on Thursday. Brussels signed the deal on behalf of EU states for the supply of at least 300 million doses of its COVID-19 vaccine candidate. It has an option for a further 100 million, the spokesman said.
“We cannot indicate at this stage the specific pricing per dose. However, a significant part of the overall costs are funded by a contribution from the overall ESI funding for vaccines,” he said, referring to the bloc’s so-called emergency support instrument.
How much money have nations poured into this company now? For a product no one knows will even work? 🤯 ✌🐸
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Could U.S. regulators authorize a COVID-19 vaccine before the election?U.S. President Donald Trump has said a vaccine for the novel coronavirus could be available before the Nov. 3 presidential election, sooner than most experts anticipate. Does Trump tweet from the can? Of course he's going to pressure regulators to approve or be fired. Sure. Trump could force authorization of a vaccine right before the election. Doesn't matter if it kills u. Depends who regulates their pocketbook.
Source: Reuters - 🏆 2. / 97 Read more »
How L.A. doctors plan to include more people of color in COVID-19 vaccine trialDoctors at Harbor-UCLA are participating in a COVID-19 vaccine trial, and they're aiming to recruit people of color and members of other high-risk groups. PrimeWednesdayService “People of color” All people have color. If they don’t, then they are likely translucent. Well hopefully they don't read the LAT's, which set out on a massive effort to discredit/smear anything to do with Trump's effort - Op Warp Speed - to develop and deliver vaccines ASAP. I suspect over 40 articles doing this so far. Turning millions into anti-vaxers forever.
Source: L.A. Times Health - 🏆 364. / 59 Read more »
COVID-19 Vaccine May Pit Science Against PoliticsNew vaccines usually take years to get the approval of the Food and Drug Administration. But the Trump administration suggests the FDA may greenlight a coronavirus vaccine by the end of the year. That’s exactly what he will do We still wouldn't vote for him. This would have been more convincing before this weeks fiasco.
Source: NPRHealth - 🏆 144. / 63 Read more »
Kazakhstan secures supplies of Russian COVID-19 vaccine candidateKazakhstan has signed a deal to get supplies of Russia's first potential COVID-19 vaccine once clinical trials are complete, the Central Asian nation's government and the backers of the Russian project said on Wednesday. Did they have a choice? Kazakhstan is the first
Source: Reuters - 🏆 2. / 97 Read more »
Moderna's stock rises after it says COVID-19 vaccine candidate produced antibodies in older patientsShares of Moderna Inc. undefined gained 5.2% in trading on Wednesday after a company executive told a government advisory committee that its experimental... Check out my Gig on Fiverr: Do You Want To create 3d Amazing Video Intro Logo Animation Video In $5 ? Contact Me : LogoAnimation MadeOnFiverr Top Logo Animation Best Logo Animation See also Pfizer presentation, now ongoing at ACIP website for broadcasting, disucssing 2 doses of BNT162b2, showing neutralizing antibody titers exceeding those in human convalescent panels. $PFE Grabbed 20
Source: MarketWatch - 🏆 3. / 97 Read more »
Pfizer says COVID-19 vaccine trial more than 50 percent enrolledEnrollment in the 30,000-volunteer U.S. trial testing a COVID-19 vaccine from Pfizer Inc and German partner BioNTech is more than 50 percent complete, Dr. Nicholas Kitchin, a top Pfizer vaccine research and development scientist, said at the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices meeting on Wednesday.
Source: Reuters - 🏆 2. / 97 Read more »